99/148 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Liu DX, Pahar B, Perry DL, Xu H, Cooper TK, Huzella LM, Hart RJ, Hischak AMW, Bernbaum J, St Claire M, Byrum R, Bennett RS, Warren T, Holbrook MR, Hensley LE, et al. Depletion of Bone Marrow Hematopoietic Cells in Ebola Virus-Infected Rhesus Macaques: A Possible Cause of Hematologic Abnormalities in Ebola Virus Disease. The American Journal of Pathology. PMID 37689386 DOI: 10.1016/j.ajpath.2023.08.010  0.355
2023 Stein SR, Platt AP, Teague HL, Anthony SM, Reeder RJ, Cooper K, Byrum R, Drawbaugh DJ, Liu DX, Burdette TL, Hadley K, Barr B, Warner S, Rodriguez-Hernandez F, Johnson C, ... ... Holbrook MR, et al. Clinical and immunological correlates of vasodilatory shock among Ebola virus infected nonhuman primates in a critical care model. The Journal of Infectious Diseases. PMID 37652048 DOI: 10.1093/infdis/jiad374  0.383
2023 Postnikova E, Liang J, Yu S, Cai Y, Cong Y, Holbrook MR. Anti-Nipah Virus Enzyme-Linked Immunosorbent Assays with Non-human Primate and Hamster Serum. Methods in Molecular Biology (Clifton, N.J.). 2682: 233-244. PMID 37610586 DOI: 10.1007/978-1-0716-3283-3_17  0.395
2023 Liu DX, Pahar B, Cooper TK, Perry DL, Xu H, Huzella LM, Adams RD, Hischak AMW, Hart RJ, Bernbaum R, Rivera D, Anthony S, St Claire M, Byrum R, Cooper K, ... ... Holbrook MR, et al. Ebola Virus Disease Features Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome in the Rhesus Macaque Model. The Journal of Infectious Diseases. PMID 37279544 DOI: 10.1093/infdis/jiad203  0.322
2022 Ithinji DG, Buchholz DW, Ezzatpour S, Monreal IA, Cong Y, Sahler J, Bangar AS, Imbiakha B, Upadhye V, Liang J, Ma A, Bradel-Tretheway B, Kaza B, Yeo YY, Choi EJ, ... ... Holbrook MR, et al. Multivalent viral particles elicit safe and efficient immunoprotection against Nipah Hendra and Ebola viruses. Npj Vaccines. 7: 166. PMID 36528644 DOI: 10.1038/s41541-022-00588-5  0.387
2022 Worwa G, Cooper TK, Yeh S, Shantha JG, Hischak AMW, Klim SE, Byrum R, Kurtz JR, Anthony SM, Aiosa NM, Ragland D, Lee JH, Claire MS, Davis C, Ahmed R, ... Holbrook MR, et al. Persistent intraocular Ebola virus RNA is associated with severe uveitis in a convalescent rhesus monkey. Communications Biology. 5: 1204. PMID 36352100 DOI: 10.1038/s42003-022-04158-2  0.359
2022 Ji Y, Zhang Q, Cheng L, Ge J, Wang R, Fang M, Mucker EM, Chen P, Ma J, Zhang R, Li C, Hammond H, Baracco L, Holbrook M, Frieman M, et al. Preclinical characterization of amubarvimab and romlusevimab, a pair of non-competing neutralizing monoclonal antibody cocktail, against SARS-CoV-2. Frontiers in Immunology. 13: 980435. PMID 36189212 DOI: 10.3389/fimmu.2022.980435  0.308
2022 Milligan JC, Davis CW, Yu X, Ilinykh PA, Huang K, Halfmann PJ, Cross RW, Borisevich V, Agans KN, Geisbert JB, Chennareddy C, Goff AJ, Piper AE, Hui S, Shaffer KCL, ... ... Holbrook MR, et al. Asymmetric and non-stoichiometric glycoprotein recognition by two distinct antibodies results in broad protection against ebolaviruses. Cell. 185: 995-1007.e18. PMID 35303429 DOI: 10.1016/j.cell.2022.02.023  0.306
2021 Liu DX, Cooper TK, Perry DL, Huzella LM, Hischak AM, Hart RJ, Isic N, Byrum R, Ragland D, St Claire M, Cooper K, Reeder R, Logue J, Jahrling PB, Holbrook MR, et al. Expanded Histopathology and Tropism of Ebola Virus in the Rhesus Macaque Model: Potential for Sexual Transmission, Altered Adrenomedullary Hormone Production and Early Viral Replication in liver. The American Journal of Pathology. PMID 34626576 DOI: 10.1016/j.ajpath.2021.09.009  0.407
2020 Weston S, Baracco L, Keller C, Matthews K, McGrath ME, Logue J, Liang J, Dyall J, Holbrook MR, Hensley LE, Jahrling PB, Yu W, MacKerell AD, Frieman MB. The SKI complex is a broad-spectrum, host-directed antiviral drug target for coronaviruses, influenza, and filoviruses. Proceedings of the National Academy of Sciences of the United States of America. PMID 33184176 DOI: 10.1073/pnas.2012939117  0.302
2020 Lane TR, Dyall J, Mercer L, Goodin C, Foil DH, Zhou H, Postnikova E, Liang JY, Holbrook MR, Madrid PB, Ekins S. Repurposing Pyramax®, Quinacrine and Tilorone as Treatments for Ebola Virus Disease. Antiviral Research. 104908. PMID 32798602 DOI: 10.1016/J.Antiviral.2020.104908  0.462
2020 Lane TR, Massey C, Comer JE, Freiberg AN, Zhou H, Dyall J, Holbrook MR, Anantpadma M, Davey RA, Madrid PB, Ekins S. Pyronaridine Tetraphosphate Efficacy Against Ebola Virus Infection in Guinea Pig. Antiviral Research. 104863. PMID 32682926 DOI: 10.1016/J.Antiviral.2020.104863  0.479
2020 Solomon J, Aiosa N, Bradley D, Castro MA, Reza S, Bartos C, Sayre P, Lee JH, Sword J, Holbrook MR, Bennett RS, Hammoud DA, Johnson RF, Feuerstein I. Atlas-based liver segmentation for nonhuman primate research. International Journal of Computer Assisted Radiology and Surgery. PMID 32648161 DOI: 10.1007/S11548-020-02225-9  0.337
2019 DeWald LE, Johnson JC, Gerhardt DM, Torzewski LM, Postnikova E, Honko AN, Janosko K, Huzella L, Dowling WE, Eakin AE, Osborn BL, Gahagen J, Tang L, Green CE, Mirsalis JC, ... Holbrook MR, et al. In Vivo Activity of Amodiaquine against Ebola Virus Infection. Scientific Reports. 9: 20199. PMID 31882748 DOI: 10.1038/S41598-019-56481-0  0.485
2019 Lee JH, Hammoud DA, Cong Y, Huzella LM, Castro MA, Solomon J, Laux J, Lackemeyer M, Bohannon JK, Rojas O, Byrum R, Adams R, Ragland D, St Claire M, Munster V, ... Holbrook MR, et al. The Use of Large-Particle Aerosol Exposure to Nipah Virus to Mimic Human Neurological Disease Manifestations in the African Green Monkey. The Journal of Infectious Diseases. PMID 31687756 DOI: 10.1093/Infdis/Jiz502  0.42
2019 Postnikova EN, Pettitt J, Van Ryn CJ, Holbrook MR, Bollinger L, Yú S, Caì Y, Liang J, Sneller MC, Jahrling PB, Hensley LE, Kuhn JH, Fallah MP, Bennett RS, Reilly C. Scalable, semi-automated fluorescence reduction neutralization assay for qualitative assessment of Ebola virus-neutralizing antibodies in human clinical samples. Plos One. 14: e0221407. PMID 31454374 DOI: 10.1371/Journal.Pone.0221407  0.43
2019 Lara A, Cong Y, Jahrling PB, Mednikov M, Postnikova E, Yu S, Munster V, Holbrook MR. Peripheral immune response in the African green monkey model following Nipah-Malaysia virus exposure by intermediate-size particle aerosol. Plos Neglected Tropical Diseases. 13: e0007454. PMID 31166946 DOI: 10.1371/Journal.Pntd.0007454  0.457
2018 Hammoud DA, Lentz MR, Lara A, Bohannon JK, Feuerstein I, Huzella L, Jahrling PB, Lackemeyer M, Laux J, Rojas O, Sayre P, Solomon J, Cong Y, Munster V, Holbrook MR. Aerosol exposure to intermediate size Nipah virus particles induces neurological disease in African green monkeys. Plos Neglected Tropical Diseases. 12: e0006978. PMID 30462637 DOI: 10.1371/Journal.Pntd.0006978  0.489
2018 Sirmarova J, Salat J, Palus M, Hönig V, Langhansova H, Holbrook MR, Ruzek D. Kyasanur Forest disease virus infection activates human vascular endothelial cells and monocyte-derived dendritic cells. Emerging Microbes & Infections. 7: 175. PMID 30401896 DOI: 10.1038/S41426-018-0177-Z  0.434
2018 DeWald LE, Dyall J, Sword JM, Torzewski L, Zhou H, Postnikova E, Kollins E, Alexander I, Gross R, Cong Y, Gerhardt DM, Johnson RF, Olinger GG, Holbrook MR, Hensley LE, et al. The Calcium Channel Blocker Bepridil Demonstrates Efficacy in the Murine Model of Marburg Virus Disease. The Journal of Infectious Diseases. PMID 29982632 DOI: 10.1093/Infdis/Jiy332  0.449
2018 Holbrook MR. Will a single-cycle Adenovirus vaccine be effective against Ebola virus? The Journal of Infectious Diseases. PMID 29982527 DOI: 10.1093/infdis/jiy412  0.369
2018 Dyall J, Nelson EA, DeWald LE, Guha R, Hart BJ, Zhou H, Postnikova E, Logue J, Vargas WM, Gross R, Michelotti J, Deiuliis N, Bennett RS, Crozier I, Holbrook MR, et al. Identification of Combinations of Approved Drugs With Synergistic Activity Against Ebola Virus in Cell Cultures. The Journal of Infectious Diseases. PMID 29939303 DOI: 10.1093/Infdis/Jiy304  0.326
2018 Jensen KS, Adams R, Bennett RS, Bernbaum J, Jahrling PB, Holbrook MR. Development of a novel real-time polymerase chain reaction assay for the quantitative detection of Nipah virus replicative viral RNA. Plos One. 13: e0199534. PMID 29920552 DOI: 10.1371/Journal.Pone.0199534  0.425
2018 Postnikova E, Cong Y, DeWald LE, Dyall J, Yu S, Hart BJ, Zhou H, Gross R, Logue J, Cai Y, Deiuliis N, Michelotti J, Honko AN, Bennett RS, Holbrook MR, et al. Testing therapeutics in cell-based assays: Factors that influence the apparent potency of drugs. Plos One. 13: e0194880. PMID 29566079 DOI: 10.1371/Journal.Pone.0194880  0.419
2018 Cong Y, Hart BJ, Gross R, Zhou H, Frieman M, Bollinger L, Wada J, Hensley LE, Jahrling PB, Dyall J, Holbrook MR. MERS-CoV pathogenesis and antiviral efficacy of licensed drugs in human monocyte-derived antigen-presenting cells. Plos One. 13: e0194868. PMID 29566060 DOI: 10.1371/Journal.Pone.0194868  0.414
2018 Perry DL, Huzella LM, Bernbaum JG, Holbrook MR, Jahrling PB, Hagen KR, Schnell MJ, Johnson RF. Ebola Virus Localization in the Macaque Reproductive Tract during Acute Ebola Virus Disease. The American Journal of Pathology. PMID 29429544 DOI: 10.1016/J.Ajpath.2017.11.004  0.432
2017 Walpita P, Cong Y, Jahrling PB, Rojas O, Postnikova E, Yu S, Johns L, Holbrook MR. A VLP-based vaccine provides complete protection against Nipah virus challenge following multiple-dose or single-dose vaccination schedules in a hamster model. Npj Vaccines. 2: 21. PMID 29263876 DOI: 10.1038/s41541-017-0023-7  0.474
2017 McAuley AJ, Sawatsky B, Ksiazek T, Torres M, Korva M, Lotrič-Furlan S, Avšič-Županc T, von Messling V, Holbrook MR, Freiberg AN, Beasley DWC, Bente DA. Cross-neutralisation of viruses of the tick-borne encephalitis complex following tick-borne encephalitis vaccination and/or infection. Npj Vaccines. 2: 5. PMID 29263866 DOI: 10.1038/s41541-017-0009-5  0.444
2017 Holbrook MR. Historical Perspectives on Flavivirus Research. Viruses. 9. PMID 28468299 DOI: 10.3390/V9050097  0.509
2017 Cong Y, Lentz MR, Lara A, Alexander I, Bartos C, Bohannon JK, Hammoud D, Huzella L, Jahrling PB, Janosko K, Jett C, Kollins E, Lackemeyer M, Mollura D, Ragland D, ... ... Holbrook MR, et al. Loss in lung volume and changes in the immune response demonstrate disease progression in African green monkeys infected by small-particle aerosol and intratracheal exposure to Nipah virus. Plos Neglected Tropical Diseases. 11: e0005532. PMID 28388650 DOI: 10.1371/Journal.Pntd.0005532  0.402
2016 Cong Y, Dyall J, Hart BJ, DeWald LE, Johnson JC, Postnikova E, Zhou H, Gross R, Rojas O, Alexander I, Josleyn N, Zhang T, Michelotti J, Janosko K, Glass PJ, ... ... Holbrook MR, et al. Evaluation of the Activity of Lamivudine and Zidovudine against Ebola Virus. Plos One. 11: e0166318. PMID 27902714 DOI: 10.1371/Journal.Pone.0166318  0.549
2016 Cong Y, McArthur MA, Cohen M, Jahrling PB, Janosko KB, Josleyn N, Kang K, Zhang T, Holbrook MR. Characterization of Yellow Fever Virus Infection of Human and Non-human Primate Antigen Presenting Cells and Their Interaction with CD4+ T Cells. Plos Neglected Tropical Diseases. 10: e0004709. PMID 27191161 DOI: 10.1371/Journal.Pntd.0004709  0.75
2016 Luke T, Wu H, Zhao J, Channappanavar R, Coleman CM, Jiao JA, Matsushita H, Liu Y, Postnikova EN, Ork BL, Glenn G, Flyer D, Defang G, Raviprakash K, Kochel T, ... ... Holbrook MR, et al. Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo. Science Translational Medicine. 8: 326ra21. PMID 26888429 DOI: 10.1126/Scitranslmed.Aaf1061  0.431
2016 Johnson RF, Bagci U, Keith L, Tang X, Mollura DJ, Zeitlin L, Qin J, Huzella L, Bartos CJ, Bohorova N, Bohorov O, Goodman C, Kim DH, Paulty MH, Velasco J, ... ... Holbrook MR, et al. 3B11-N, a monoclonal antibody against MERS-CoV, reduces lung pathology in rhesus monkeys following intratracheal inoculation of MERS-CoV Jordan-n3/2012. Virology. 490: 49-58. PMID 26828465 DOI: 10.1016/J.Virol.2016.01.004  0.328
2015 Johnson RF, Via LE, Kumar MR, Cornish JP, Yellayi S, Huzella L, Postnikova E, Oberlander N, Bartos C, Ork BL, Mazur S, Allan C, Holbrook MR, Solomon J, Johnson JC, et al. Intratracheal exposure of common marmosets to MERS-CoV Jordan-n3/2012 or MERS-CoV EMC/2012 isolates does not result in lethal disease. Virology. 485: 422-430. PMID 26342468 DOI: 10.1016/J.Virol.2015.07.013  0.377
2015 Kumar M, Mazur S, Ork BL, Postnikova E, Hensley LE, Jahrling PB, Johnson R, Holbrook MR. Inactivation and safety testing of Middle East Respiratory Syndrome Coronavirus. Journal of Virological Methods. 223: 13-8. PMID 26190637 DOI: 10.1016/J.Jviromet.2015.07.002  0.434
2015 Christie A, Davies-Wayne GJ, Cordier-Lasalle T, Blackley DJ, Laney AS, Williams DE, Shinde SA, Badio M, Lo T, Mate SE, Ladner JT, Wiley MR, Kugelman JR, Palacios G, Holbrook MR, et al. Possible sexual transmission of ebola virus - liberia, 2015. Mmwr. Morbidity and Mortality Weekly Report. 64: 479-81. PMID 25950255  0.327
2015 Roberts KK, Hill TE, Davis MN, Holbrook MR, Freiberg AN. Cytokine Response in Mouse Bone Marrow Derived Macrophages After Infection with Pathogenic and Non-pathogenic Rift Valley Fever Virus. The Journal of General Virology. PMID 25759029 DOI: 10.1099/Vir.0.000119  0.466
2015 Kindrachuk J, Ork B, Hart BJ, Mazur S, Holbrook MR, Frieman MB, Traynor D, Johnson RF, Dyall J, Kuhn JH, Olinger GG, Hensley LE, Jahrling PB. Antiviral potential of ERK/MAPK and PI3K/AKT/mTOR signaling modulation for Middle East respiratory syndrome coronavirus infection as identified by temporal kinome analysis. Antimicrobial Agents and Chemotherapy. 59: 1088-99. PMID 25487801 DOI: 10.1128/Aac.03659-14  0.407
2014 Smith DR, Holbrook MR, Gowen BB. Animal models of viral hemorrhagic fever. Antiviral Research. 112: 59-79. PMID 25448088 DOI: 10.1016/J.Antiviral.2014.10.001  0.422
2014 Sawatsky B, McAuley AJ, Holbrook MR, Bente DA. Comparative pathogenesis of Alkhumra hemorrhagic fever and Kyasanur forest disease viruses in a mouse model. Plos Neglected Tropical Diseases. 8: e2934. PMID 24922308 DOI: 10.1371/Journal.Pntd.0002934  0.516
2014 Dyall J, Coleman CM, Hart BJ, Venkataraman T, Holbrook MR, Kindrachuk J, Johnson RF, Olinger GG, Jahrling PB, Laidlaw M, Johansen LM, Lear-Rooney CM, Glass PJ, Hensley LE, Frieman MB. Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection. Antimicrobial Agents and Chemotherapy. 58: 4885-93. PMID 24841273 DOI: 10.1128/Aac.03036-14  0.308
2014 Yoshii K, Sunden Y, Yokozawa K, Igarashi M, Kariwa H, Holbrook MR, Takashima I. A critical determinant of neurological disease associated with highly pathogenic tick-borne flavivirus in mice. Journal of Virology. 88: 5406-20. PMID 24574402 DOI: 10.1128/Jvi.00421-14  0.494
2014 Hart BJ, Dyall J, Postnikova E, Zhou H, Kindrachuk J, Johnson RF, Olinger GG, Frieman MB, Holbrook MR, Jahrling PB, Hensley L. Interferon-β and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays. The Journal of General Virology. 95: 571-7. PMID 24323636 DOI: 10.1099/Vir.0.061911-0  0.379
2013 Blaney JE, Marzi A, Willet M, Papaneri AB, Wirblich C, Feldmann F, Holbrook M, Jahrling P, Feldmann H, Schnell MJ. Antibody Quality and Protection from Lethal Ebola Virus Challenge in Nonhuman Primates Immunized with Rabies Virus Based Bivalent Vaccine Plos Pathogens. 9. PMID 23737747 DOI: 10.1371/Journal.Ppat.1003389  0.444
2013 Woodson SE, Freiberg AN, Holbrook MR. Coagulation factors, fibrinogen and plasminogen activator inhibitor-1, are differentially regulated by yellow fever virus infection of hepatocytes. Virus Research. 175: 155-9. PMID 23639427 DOI: 10.1016/J.Virusres.2013.04.013  0.784
2012 Lok SM, Costin JM, Hrobowski YM, Hoffmann AR, Rowe DK, Kukkaro P, Holdaway H, Chipman P, Fontaine KA, Holbrook MR, Garry RF, Kostyuchenko V, Wimley WC, Isern S, Rossmann MG, et al. Release of dengue virus genome induced by a peptide inhibitor. Plos One. 7: e50995. PMID 23226444 DOI: 10.1371/Journal.Pone.0050995  0.478
2012 Holbrook MR. Kyasanur forest disease. Antiviral Research. 96: 353-62. PMID 23110991 DOI: 10.1016/J.Antiviral.2012.10.005  0.507
2012 Rusu M, Bonneau R, Holbrook MR, Watowich SJ, Birmanns S, Wriggers W, Freiberg AN. An assembly model of rift valley Fever virus. Frontiers in Microbiology. 3: 254. PMID 22837754 DOI: 10.3389/Fmicb.2012.00254  0.492
2012 Gray KK, Worthy MN, Juelich TL, Agar SL, Poussard A, Ragland D, Freiberg AN, Holbrook MR. Chemotactic and inflammatory responses in the liver and brain are associated with pathogenesis of Rift Valley fever virus infection in the mouse. Plos Neglected Tropical Diseases. 6: e1529. PMID 22389738 DOI: 10.1371/Journal.Pntd.0001529  0.514
2011 Lehrer AT, Holbrook MR. Tick-borne Encephalitis Vaccines. Journal of Bioterrorism & Biodefense. 2011: 3. PMID 23997980 DOI: 10.4172/2157-2526.S1-003  0.406
2011 McArthur MA, Holbrook MR. Japanese Encephalitis Vaccines. Journal of Bioterrorism & Biodefense. 2. PMID 23125946 DOI: 10.4172/2157-2526.S1-002  0.691
2011 Papin JF, Verardi PH, Jones LA, Monge-Navarro F, Brault AC, Holbrook MR, Worthy MN, Freiberg AN, Yilma TD. Recombinant Rift Valley fever vaccines induce protective levels of antibody in baboons and resistance to lethal challenge in mice. Proceedings of the National Academy of Sciences of the United States of America. 108: 14926-31. PMID 21873194 DOI: 10.1073/Pnas.1112149108  0.434
2011 Blaney JE, Wirblich C, Papaneri AB, Johnson RF, Myers CJ, Juelich TL, Holbrook MR, Freiberg AN, Bernbaum JG, Jahrling PB, Paragas J, Schnell MJ. Inactivated or live-attenuated bivalent vaccines that confer protection against rabies and Ebola viruses. Journal of Virology. 85: 10605-16. PMID 21849459 DOI: 10.1128/Jvi.00558-11  0.435
2011 Woodson SE, Holbrook MR. Infection of hepatocytes with 17-D vaccine-strain yellow fever virus induces a strong pro-inflammatory host response. The Journal of General Virology. 92: 2262-71. PMID 21697351 DOI: 10.1099/Vir.0.031617-0  0.804
2011 Woodson SE, Freiberg AN, Holbrook MR. Differential cytokine responses from primary human Kupffer cells following infection with wild-type or vaccine strain yellow fever virus. Virology. 412: 188-95. PMID 21277609 DOI: 10.1016/J.Virol.2011.01.012  0.78
2011 Mendenhall M, Russell A, Juelich T, Messina EL, Smee DF, Freiberg AN, Holbrook MR, Furuta Y, de la Torre JC, Nunberg JH, Gowen BB. T-705 (favipiravir) inhibition of arenavirus replication in cell culture. Antimicrobial Agents and Chemotherapy. 55: 782-7. PMID 21115797 DOI: 10.1128/Aac.01219-10  0.479
2011 Zhou Z, Wang N, Woodson SE, Dong Q, Wang J, Liang Y, Rijnbrand R, Wei L, Nichols JE, Guo JT, Holbrook MR, Lemon SM, Li K. Antiviral activities of ISG20 in positive-strand RNA virus infections. Virology. 409: 175-88. PMID 21036379 DOI: 10.1016/J.Virol.2010.10.008  0.792
2011 Yoshii K, Igarashi M, Ito K, Kariwa H, Holbrook MR, Takashima I. Construction of an infectious cDNA clone for Omsk hemorrhagic fever virus, and characterization of mutations in NS2A and NS5. Virus Research. 155: 61-8. PMID 20817056 DOI: 10.1016/J.Virusres.2010.08.023  0.494
2010 Wang YE, Park A, Lake M, Pentecost M, Torres B, Yun TE, Wolf MC, Holbrook MR, Freiberg AN, Lee B. Ubiquitin-regulated nuclear-cytoplasmic trafficking of the Nipah virus matrix protein is important for viral budding. Plos Pathogens. 6: e1001186. PMID 21085610 DOI: 10.1371/Journal.Ppat.1001186  0.462
2010 Van Regenmortel MH, Burke DS, Calisher CH, Dietzgen RG, Fauquet CM, Ghabrial SA, Jahrling PB, Johnson KM, Holbrook MR, Horzinek MC, Keil GM, Kuhn JH, Mahy BW, Martelli GP, Pringle C, et al. A proposal to change existing virus species names to non-Latinized binomials. Archives of Virology. 155: 1909-19. PMID 20953644 DOI: 10.1007/S00705-010-0831-9  0.431
2010 Tigabu B, Juelich T, Holbrook MR. Comparative analysis of immune responses to Russian spring-summer encephalitis and Omsk hemorrhagic fever viruses in mouse models. Virology. 408: 57-63. PMID 20875909 DOI: 10.1016/J.Virol.2010.08.021  0.405
2010 Mandell RB, Koukuntla R, Mogler LJ, Carzoli AK, Holbrook MR, Martin BK, Vahanian N, Link CJ, Flick R. Novel suspension cell-based vaccine production systems for Rift Valley fever virus-like particles. Journal of Virological Methods. 169: 259-68. PMID 20655330 DOI: 10.1016/J.Jviromet.2010.07.015  0.418
2010 LaSala PR, Holbrook M. Tick-Borne Flaviviruses Clinics in Laboratory Medicine. 30: 221-235. PMID 20513549 DOI: 10.1016/J.Cll.2010.01.002  0.527
2010 Fang H, Welte T, Zheng X, Chang GJ, Holbrook MR, Soong L, Wang T. gammadelta T cells promote the maturation of dendritic cells during West Nile virus infection. Fems Immunology and Medical Microbiology. 59: 71-80. PMID 20337718 DOI: 10.1111/J.1574-695X.2010.00663.X  0.362
2010 Wolf MC, Freiberg AN, Zhang T, Akyol-Ataman Z, Grock A, Hong PW, Li J, Watson NF, Fang AQ, Aguilar HC, Porotto M, Honko AN, Damoiseaux R, Miller JP, Woodson SE, ... ... Holbrook MR, et al. A broad-spectrum antiviral targeting entry of enveloped viruses. Proceedings of the National Academy of Sciences of the United States of America. 107: 3157-62. PMID 20133606 DOI: 10.1073/Pnas.0909587107  0.792
2010 Laurent-Rolle M, Boer EF, Lubick KJ, Wolfinbarger JB, Carmody AB, Rockx B, Liu W, Ashour J, Shupert WL, Holbrook MR, Barrett AD, Mason PW, Bloom ME, García-Sastre A, Khromykh AA, et al. The NS5 protein of the virulent West Nile virus NY99 strain is a potent antagonist of type I interferon-mediated JAK-STAT signaling. Journal of Virology. 84: 3503-15. PMID 20106931 DOI: 10.1128/Jvi.01161-09  0.669
2010 Mandell RB, Koukuntla R, Mogler LJ, Carzoli AK, Freiberg AN, Holbrook MR, Martin BK, Staplin WR, Vahanian NN, Link CJ, Flick R. A replication-incompetent Rift Valley fever vaccine: chimeric virus-like particles protect mice and rats against lethal challenge. Virology. 397: 187-98. PMID 19932911 DOI: 10.1016/J.Virol.2009.11.001  0.504
2010 Freiberg AN, Worthy MN, Lee B, Holbrook MR. Combined chloroquine and ribavirin treatment does not prevent death in a hamster model of Nipah and Hendra virus infection. The Journal of General Virology. 91: 765-72. PMID 19889926 DOI: 10.1099/Vir.0.017269-0  0.531
2009 Kolokoltsov AA, Saeed MF, Freiberg AN, Holbrook MR, Davey RA. Identification of novel cellular targets for therapeutic intervention against Ebola virus infection by siRNA screening. Drug Development Research. 70: 255-265. PMID 20930947 DOI: 10.1002/Ddr.20303  0.668
2009 Holman DH, Penn-Nicholson A, Wang D, Woraratanadharm J, Harr MK, Luo M, Maher EM, Holbrook MR, Dong JY. A complex adenovirus-vectored vaccine against Rift Valley fever virus protects mice against lethal infection in the presence of preexisting vector immunity. Clinical and Vaccine Immunology : Cvi. 16: 1624-32. PMID 19776190 DOI: 10.1128/Cvi.00182-09  0.474
2009 Wolf MC, Wang Y, Freiberg AN, Aguilar HC, Holbrook MR, Lee B. A catalytically and genetically optimized beta-lactamase-matrix based assay for sensitive, specific, and higher throughput analysis of native henipavirus entry characteristics. Virology Journal. 6: 119. PMID 19646266 DOI: 10.1186/1743-422X-6-119  0.443
2009 Tigabu B, Juelich T, Bertrand J, Holbrook MR. Clinical evaluation of highly pathogenic tick-borne flavivirus infection in the mouse model. Journal of Medical Virology. 81: 1261-9. PMID 19475605 DOI: 10.1002/Jmv.21524  0.438
2009 Sherman MB, Freiberg AN, Holbrook MR, Watowich SJ. Single-particle cryo-electron microscopy of Rift Valley fever virus. Virology. 387: 11-5. PMID 19304307 DOI: 10.1016/J.Virol.2009.02.038  0.486
2009 Yoshii K, Holbrook MR. Sub-genomic replicon and virus-like particles of Omsk hemorrhagic fever virus. Archives of Virology. 154: 573-80. PMID 19277843 DOI: 10.1007/S00705-009-0345-5  0.519
2008 Saeed MF, Kolokoltsov AA, Freiberg AN, Holbrook MR, Davey RA. Phosphoinositide-3 kinase-Akt pathway controls cellular entry of Ebola virus. Plos Pathogens. 4: e1000141. PMID 18769720 DOI: 10.1371/Journal.Ppat.1000141  0.711
2008 Freiberg AN, Sherman MB, Morais MC, Holbrook MR, Watowich SJ. Three-dimensional organization of Rift Valley fever virus revealed by cryoelectron tomography. Journal of Virology. 82: 10341-8. PMID 18715915 DOI: 10.1128/Jvi.01191-08  0.517
2008 Yun NE, Linde NS, Zacks MA, Barr IG, Hurt AC, Smith JN, Dziuba N, Holbrook MR, Zhang L, Kilpatrick JM, Arnold CS, Paessler S. Injectable peramivir mitigates disease and promotes survival in ferrets and mice infected with the highly virulent influenza virus, A/Vietnam/1203/04 (H5N1). Virology. 374: 198-209. PMID 18234269 DOI: 10.1016/J.Virol.2007.12.029  0.472
2008 Gowen BB, Holbrook MR. Animal models of highly pathogenic RNA viral infections: hemorrhagic fever viruses. Antiviral Research. 78: 79-90. PMID 18036672 DOI: 10.1016/J.Antiviral.2007.10.002  0.498
2008 Holbrook MR, Gowen BB. Animal models of highly pathogenic RNA viral infections: encephalitis viruses. Antiviral Research. 78: 69-78. PMID 18031836 DOI: 10.1016/J.Antiviral.2007.10.004  0.509
2006 Volk DE, Chavez L, Beasley DW, Barrett AD, Holbrook MR, Gorenstein DG. Structure of the envelope protein domain III of Omsk hemorrhagic fever virus. Virology. 351: 188-95. PMID 16647096 DOI: 10.1016/J.Virol.2006.03.030  0.627
2005 Khaiboullina SF, Rizvanov AA, Holbrook MR, St Jeor S. Yellow fever virus strains Asibi and 17D-204 infect human umbilical cord endothelial cells and induce novel changes in gene expression. Virology. 342: 167-76. PMID 16150475 DOI: 10.1016/J.Virol.2005.07.035  0.44
2005 Holbrook MR, Aronson JF, Campbell GA, Jones S, Feldmann H, Barrett AD. An animal model for the tickborne flavivirus--Omsk hemorrhagic fever virus. The Journal of Infectious Diseases. 191: 100-8. PMID 15593010 DOI: 10.1086/426397  0.673
2004 Holbrook MR, Shope RE, Barrett AD. Use of recombinant E protein domain III-based enzyme-linked immunosorbent assays for differentiation of tick-borne encephalitis serocomplex flaviviruses from mosquito-borne flaviviruses. Journal of Clinical Microbiology. 42: 4101-10. PMID 15364996 DOI: 10.1128/Jcm.42.9.4101-4110.2004  0.608
2004 Yu S, Wuu A, Basu R, Holbrook MR, Barrett AD, Lee JC. Solution structure and structural dynamics of envelope protein domain III of mosquito- and tick-borne flaviviruses. Biochemistry. 43: 9168-76. PMID 15248774 DOI: 10.1021/Bi049324G  0.604
2004 Volk DE, Kallick DA, Holbrook MR, Beasley DW, Barrett AD, Gorenstein DG. 1H, 13C and 15N resonance assignments for domain III of the West Nile virus envelope protein. Journal of Biomolecular Nmr. 29: 445-6. PMID 15213461 DOI: 10.1023/B:Jnmr.0000032551.56061.68  0.583
2004 Volk DE, Beasley DW, Kallick DA, Holbrook MR, Barrett AD, Gorenstein DG. Solution structure and antibody binding studies of the envelope protein domain III from the New York strain of West Nile virus. The Journal of Biological Chemistry. 279: 38755-61. PMID 15190071 DOI: 10.1074/Jbc.M402385200  0.539
2004 Beasley DW, Holbrook MR, Travassos Da Rosa AP, Coffey L, Carrara AS, Phillippi-Falkenstein K, Bohm RP, Ratterree MS, Lillibridge KM, Ludwig GV, Estrada-Franco J, Weaver SC, Tesh RB, Shope RE, Barrett AD. Use of a recombinant envelope protein subunit antigen for specific serological diagnosis of West Nile virus infection. Journal of Clinical Microbiology. 42: 2759-65. PMID 15184463 DOI: 10.1128/Jcm.42.6.2759-2765.2004  0.666
2004 Li L, Rollin PE, Nichol ST, Shope RE, Barrett AD, Holbrook MR. Molecular determinants of antigenicity of two subtypes of the tick-borne flavivirus Omsk haemorrhagic fever virus. The Journal of General Virology. 85: 1619-24. PMID 15166446 DOI: 10.1099/Vir.0.19766-0  0.647
2003 Lin D, Li L, Dick D, Shope RE, Feldmann H, Barrett AD, Holbrook MR. Analysis of the complete genome of the tick-borne flavivirus Omsk hemorrhagic fever virus. Virology. 313: 81-90. PMID 12951023 DOI: 10.1016/S0042-6822(03)00246-0  0.689
2003 White MA, Liu D, Holbrook MR, Shope RE, Barrett AD, Fox RO. Crystallization and preliminary X-ray diffraction analysis of Langat virus envelope protein domain III. Acta Crystallographica. Section D, Biological Crystallography. 59: 1049-51. PMID 12777770 DOI: 10.1107/S0907444903004475  0.513
2002 Holbrook MR, Barrett AD. Molecular epidemiology of Japanese encephalitis virus. Current Topics in Microbiology and Immunology. 267: 75-90. PMID 12083001 DOI: 10.1007/978-3-642-59403-8_4  0.668
2001 Beasley DW, Suderman MT, Holbrook MR, Barrett AD. Nucleotide sequencing and serological evidence that the recently recognized deer tick virus is a genotype of Powassan virus. Virus Research. 79: 81-9. PMID 11551648 DOI: 10.1016/S0168-1702(01)00330-6  0.661
2001 Holbrook MR, Ni H, Shope RE, Barrett AD. Amino acid substitution(s) in the stem-anchor region of langat virus envelope protein attenuates mouse neurovirulence. Virology. 286: 54-61. PMID 11448158 DOI: 10.1006/Viro.2001.0959  0.618
2001 Bhardwaj S, Holbrook M, Shope RE, Barrett AD, Watowich SJ. Biophysical characterization and vector-specific antagonist activity of domain III of the tick-borne flavivirus envelope protein. Journal of Virology. 75: 4002-7. PMID 11264392 DOI: 10.1128/Jvi.75.8.4002-4007.2001  0.567
2001 Holbrook MR, Wang H, Barrett AD. Langat virus M protein is structurally homologous to prM. Journal of Virology. 75: 3999-4001. PMID 11264391 DOI: 10.1128/Jvi.75.8.3999-4001.2001  0.598
2001 Wang H, Beasley DW, Li L, Holbrook MR, Barrett AD. Nucleotide sequence and deduced amino acid sequence of the medium RNA segment of Oropouche, a Simbu serogroup virus: comparison with the middle RNA of Bunyamwera and California serogroup viruses. Virus Research. 73: 153-62. PMID 11172919 DOI: 10.1016/S0168-1702(00)00234-3  0.576
2000 Holbrook MR, Li L, Suderman MT, Wang H, Barrett AD. The French neurotropic vaccine strain of yellow fever virus accumulates mutations slowly during passage in cell culture. Virus Research. 69: 31-9. PMID 10989183 DOI: 10.1016/S0168-1702(00)00168-4  0.683
1999 Holbrook MR, O'Donnell JB, Slakey LL, Gross DJ. Epidermal growth factor receptor internalization rate is regulated by negative charges near the SH2 binding site Tyr992. Biochemistry. 38: 9348-56. PMID 10413509 DOI: 10.1021/Bi990195R  0.484
Low-probability matches (unlikely to be authored by this person)
2023 Cong Y, Mucker EM, Perry DL, Dixit S, Kollins E, Byrum R, Huzella L, Kim R, Josleyn M, Kwilas S, Stefan C, Shoemaker CJ, Koehler J, Coyne S, Delp K, ... ... Holbrook MR, et al. Evaluation of a panel of therapeutic antibody clinical candidates for efficacy against SARS-CoV-2 in Syrian hamsters. Antiviral Research. 213: 105589. PMID 37003305 DOI: 10.1016/j.antiviral.2023.105589  0.298
2021 Wirnsberger G, Monteil V, Eaton B, Postnikova E, Murphy M, Braunsfeld B, Crozier I, Kricek F, Niederhöfer J, Schwarzböck A, Breid H, Sanchez Jimenez A, Bugajska-Schretter A, Dohnal A, Ruf C, ... ... Holbrook MR, et al. Clinical grade ACE2 as a universal agent to block SARS-CoV-2 variants. Biorxiv : the Preprint Server For Biology. PMID 34545368 DOI: 10.1101/2021.09.10.459744  0.296
2022 Monteil V, Eaton B, Postnikova E, Murphy M, Braunsfeld B, Crozier I, Kricek F, Niederhöfer J, Schwarzböck A, Breid H, Devignot S, Klingström J, Thålin C, Kellner MJ, Christ W, ... ... Holbrook MR, et al. Clinical grade ACE2 as a universal agent to block SARS-CoV-2 variants. Embo Molecular Medicine. e15230. PMID 35781796 DOI: 10.15252/emmm.202115230  0.293
2022 Elyanow R, Snyder TM, Dalai SC, Gittelman RM, Boonyaratanakornkit J, Wald A, Selke S, Wener MH, Morishima C, Greninger AL, Gale M, Hsiang TY, Jing L, Holbrook MR, Kaplan IM, et al. T-cell receptor sequencing identifies prior SARS-CoV-2 infection and correlates with neutralizing antibodies and disease severity. Jci Insight. PMID 35439166 DOI: 10.1172/jci.insight.150070  0.283
2018 Chefer S, Seidel J, Cockrell AS, Yount B, Solomon J, Hagen KR, Liu DX, Huzella LM, Kumar MR, Postnikova E, Bohannon JK, Lackemeyer MG, Cooper K, Endlich-Frazier A, Sharma H, ... ... Holbrook MR, et al. The Human Sodium Iodide Symporter as a Reporter Gene for Studying Middle East Respiratory Syndrome Coronavirus Pathogenesis. Msphere. 3. PMID 30541777 DOI: 10.1128/mSphere.00540-18  0.282
2022 DeGrace MM, Ghedin E, Frieman MB, Krammer F, Grifoni A, Alisoltani A, Alter G, Amara RR, Baric RS, Barouch DH, Bloom JD, Bloyet LM, Bonenfant G, Boon ACM, Boritz EA, ... ... Holbrook MR, et al. Defining the risk of SARS-CoV-2 variants on immune protection. Nature. PMID 35361968 DOI: 10.1038/s41586-022-04690-5  0.268
2023 Saphire E, Salie ZL, Ke Z, Halfmann P, DeWald LE, McArdle S, Grinyo A, Davidson E, Schendel S, Hariharan C, Norris M, Yu X, Chennareddy C, Xiong X, Heinrich M, ... Holbrook M, et al. Anti-Ebola virus mAb 3A6 with unprecedented potency protects highly viremic animals from fatal outcome and physically lifts its glycoprotein target from the virion membrane. Research Square. PMID 38196595 DOI: 10.21203/rs.3.rs-3722563/v1  0.267
2016 Mazur S, Holbrook MR, Burdette T, Joselyn N, Barr J, Pusl D, Bollinger L, Coe L, Jahrling PB, Lackemeyer MG, Wada J, Kuhn JH, Janosko K. Safety Precautions and Operating Procedures in an (A)BSL-4 Laboratory: 2. General Practices. Journal of Visualized Experiments : Jove. PMID 27768081 DOI: 10.3791/53600  0.265
2021 Bennett RS, Postnikova EN, Liang J, Gross R, Mazur S, Dixit S, Kocher G, Yu S, Georgia-Clark S, Gerhardt D, Cai Y, Marron L, Lukin VV, Holbrook MR. Scalable, Micro-Neutralization Assay for Assessment of SARS-CoV-2 (COVID-19) Virus-Neutralizing Antibodies in Human Clinical Samples. Viruses. 13. PMID 34065987 DOI: 10.3390/v13050893  0.263
2021 Bennett RS, Postnikova EN, Liang J, Gross R, Mazur S, Dixit S, Lukin VV, Kocher G, Yu S, Georgia-Clark S, Gerhardt D, Cai Y, Marron L, Holbrook MR. Scalable, Micro-Neutralization Assay for Qualitative Assessment of SARS-CoV-2 (COVID-19) Virus-Neutralizing Antibodies in Human Clinical Samples. Biorxiv : the Preprint Server For Biology. PMID 33688658 DOI: 10.1101/2021.03.05.434152  0.263
2021 Elyanow R, Snyder TM, Dalai SC, Gittelman RM, Boonyaratanakornkit J, Wald A, Selke S, Wener MH, Morishima C, Greninger AL, Holbrook MR, Kaplan IM, Zahid HJ, Carlson JM, Baldo L, et al. T-cell receptor sequencing identifies prior SARS-CoV-2 infection and correlates with neutralizing antibody titers and disease severity. Medrxiv : the Preprint Server For Health Sciences. PMID 33791723 DOI: 10.1101/2021.03.19.21251426  0.262
2022 Chen Z, Zhang P, Matsuoka Y, Tsybovsky Y, West K, Santos C, Boyd LF, Nguyen H, Pomerenke A, Stephens T, Olia AS, De Giorgi V, Holbrook MR, Gross R, Postnikova E, et al. Extremely potent monoclonal antibodies neutralize Omicron and other SARS-CoV-2 variants. Medrxiv : the Preprint Server For Health Sciences. PMID 35043120 DOI: 10.1101/2022.01.12.22269023  0.259
2016 Byrum R, Keith L, Bartos C, St Claire M, Lackemeyer MG, Holbrook MR, Janosko K, Barr J, Pusl D, Bollinger L, Wada J, Coe L, Hensley LE, Jahrling PB, Kuhn JH, et al. Safety Precautions and Operating Procedures in an (A)BSL-4 Laboratory: 4. Medical Imaging Procedures. Journal of Visualized Experiments : Jove. PMID 27768056 DOI: 10.3791/53601  0.252
2022 Ford ES, Mayer-Blackwell K, Jing L, Sholukh AM, Germain RS, Bossard EL, Xie H, Pulliam TH, Jani S, Selke S, Burrow CJ, McClurkan CL, Wald A, Holbrook MR, Eaton B, et al. CD8+ T cell clonotypes from prior SARS-CoV-2 infection predominate during the cellular immune response to mRNA vaccination. Research Square. PMID 36263073 DOI: 10.21203/rs.3.rs-2146712/v1  0.247
2023 Lackemeyer MG, Bohannon JK, Holbrook MR. Nipah Virus Aerosol Challenge of Three Distinct Particle Sizes in Nonhuman Primates. Methods in Molecular Biology (Clifton, N.J.). 2682: 175-189. PMID 37610582 DOI: 10.1007/978-1-0716-3283-3_13  0.244
2021 Cho H, Gonzales-Wartz KK, Huang D, Yuan M, Peterson M, Liang J, Beutler N, Torres JL, Cong Y, Postnikova E, Bangaru S, Talana CA, Shi W, Yang ES, Zhang Y, ... ... Holbrook M, et al. Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern. Science Translational Medicine. eabj5413. PMID 34519517 DOI: 10.1126/scitranslmed.abj5413  0.244
2016 Bohannon JK, Janosko K, Holbrook MR, Barr J, Pusl D, Bollinger L, Coe L, Hensley LE, Jahrling PB, Wada J, Kuhn JH, Lackemeyer MG. Safety Precautions and Operating Procedures in an (A)BSL-4 Laboratory: 3. Aerobiology. Journal of Visualized Experiments : Jove. PMID 27768036 DOI: 10.3791/53602  0.241
2016 Janosko K, Holbrook MR, Adams R, Barr J, Bollinger L, Newton JT, Ntiforo C, Coe L, Wada J, Pusl D, Jahrling PB, Kuhn JH, Lackemeyer MG. Safety Precautions and Operating Procedures in an (A)BSL-4 Laboratory: 1. Biosafety Level 4 Suit Laboratory Suite Entry and Exit Procedures. Journal of Visualized Experiments : Jove. PMID 27768063 DOI: 10.3791/52317  0.235
2010 Allred AF, Wu G, Wulan T, Fischer KF, Holbrook MR, Tesh RB, Wang D. VIPR: A probabilistic algorithm for analysis of microbial detection microarrays. Bmc Bioinformatics. 11: 384. PMID 20646301 DOI: 10.1186/1471-2105-11-384  0.233
2021 De Giorgi V, West KA, Henning AN, Chen LN, Holbrook MR, Gross R, Liang J, Postnikova E, Trenbeath J, Pogue S, Scinto T, Alter HJ, Cantilena CC. Naturally acquired SARS-CoV-2 immunity persists for up to 11 months following infection. The Journal of Infectious Diseases. PMID 34089610 DOI: 10.1093/infdis/jiab295  0.225
2022 Ramos-Benitez MJ, Strich JR, Alehashemi S, Stein S, Rastegar A, de Jesus AA, Bhuyan F, Ramelli S, Babyak A, Perez-Valencia L, Vannella KM, Grubbs G, Khurana S, Gross R, Hadley K, ... ... Holbrook MR, et al. Antiviral innate immunity is diminished in the upper respiratory tract of severe COVID-19 patients. Medrxiv : the Preprint Server For Health Sciences. PMID 36415460 DOI: 10.1101/2022.11.08.22281846  0.218
2009 LeDuc JW, Anderson K, Bloom ME, Carrion R, Feldmann H, Fitch JP, Geisbert JB, Geisbert TW, Holbrook MR, Jahrling PB, Ksiazek TG. Potential impact of a 2-person security rule on BioSafety Level 4 laboratory workers. Emerging Infectious Diseases. 15: e1. PMID 19624910 DOI: 10.3201/Eid1507.081523  0.213
2021 Finch CL, Dyall J, Xu S, Nelson EA, Postnikova E, Liang JY, Zhou H, DeWald LE, Thomas CJ, Wang A, Xu X, Hughes E, Morris PJ, Mirsalis JC, Nguyen LH, ... ... Holbrook MR, et al. Formulation, Stability, Pharmacokinetic, and Modeling Studies for Tests of Synergistic Combinations of Orally Available Approved Drugs against Ebola Virus In Vivo. Microorganisms. 9. PMID 33801811 DOI: 10.3390/microorganisms9030566  0.206
2022 Chen Z, Zhang P, Matsuoka Y, Tsybovsky Y, West K, Santos C, Boyd LF, Nguyen H, Pomerenke A, Stephens T, Olia AS, Zhang B, De Giorgi V, Holbrook MR, Gross R, et al. Potent monoclonal antibodies neutralize Omicron sublineages and other SARS-CoV-2 variants. Cell Reports. 111528. PMID 36302375 DOI: 10.1016/j.celrep.2022.111528  0.206
2023 Ford ES, Mayer-Blackwell K, Jing L, Laing KJ, Sholukh AM, St Germain R, Bossard EL, Xie H, Pulliam TH, Jani S, Selke S, Burrow CJ, McClurkan CL, Wald A, Greninger AL, ... Holbrook MR, et al. Repeated mRNA vaccination sequentially boosts SARS-CoV-2-specific CD8 T cells in persons with previous COVID-19. Nature Immunology. PMID 38057617 DOI: 10.1038/s41590-023-01692-x  0.202
2022 Dacon C, Tucker C, Peng L, Lee CD, Lin TH, Yuan M, Cong Y, Wang L, Purser L, Williams JK, Pyo CW, Kosik I, Hu Z, Zhao M, Mohan D, ... ... Holbrook MR, et al. Broadly neutralizing antibodies target the coronavirus fusion peptide. Science (New York, N.Y.). eabq3773. PMID 35857439 DOI: 10.1126/science.abq3773  0.201
2008 Le Duc JW, Anderson K, Bloom ME, Estep JE, Feldmann H, Geisbert JB, Geisbert TW, Hensley L, Holbrook M, Jahrling PB, Ksiazek TG, Korch G, Patterson J, Skvorak JP, Weingartl H. Framework for leadership and training of Biosafety Level 4 laboratory workers. Emerging Infectious Diseases. 14: 1685-8. PMID 18976549 DOI: 10.3201/Eid1411.080741  0.196
2023 Dickey TH, Ma R, Orr-Gonzalez S, Ouahes T, Patel P, McAleese H, Butler B, Eudy E, Eaton B, Murphy M, Kwan JL, Salinas ND, Holbrook MR, Lambert LE, Tolia NH. Design of a stabilized RBD enables potently neutralizing SARS-CoV-2 single-component nanoparticle vaccines. Cell Reports. 42: 112266. PMID 36943870 DOI: 10.1016/j.celrep.2023.112266  0.194
2021 Cho H, Gonzales-Wartz KK, Huang D, Yuan M, Peterson M, Liang J, Beutler N, Torres JL, Cong Y, Postnikova E, Bangaru S, Talana CA, Shi W, Yang ES, Zhang Y, ... ... Holbrook M, et al. Ultrapotent bispecific antibodies neutralize emerging SARS-CoV-2 variants. Biorxiv : the Preprint Server For Biology. PMID 33821267 DOI: 10.1101/2021.04.01.437942  0.191
2022 Dacon C, Tucker C, Peng L, Lee CD, Lin TH, Yuan M, Cong Y, Wang L, Purser L, Williams JK, Pyo CW, Kosik I, Hu Z, Zhao M, Mohan D, ... ... Holbrook MR, et al. Broadly neutralizing antibodies target the coronavirus fusion peptide. Biorxiv : the Preprint Server For Biology. PMID 35441178 DOI: 10.1101/2022.04.11.487879  0.191
2021 Miller MJ, Skrzekut A, Kracalik I, Jones JM, Lofy KH, Konkle BA, Haley NR, Duvenhage M, Bonnett T, Holbrook M, Higgs E, Basavaraju SV, Paranjape S. How do I… facilitate a rapid response to a public health emergency requiring plasma collection with a public-private partnership? Transfusion. PMID 34510475 DOI: 10.1111/trf.16630  0.187
2023 Cong Y, Lee JH, Perry DL, Cooper K, Wang H, Dixit S, Liu DX, Feuerstein IM, Solomon J, Bartos C, Seidel J, Hammoud DA, Adams R, Anthony SM, Liang J, ... ... Holbrook MR, et al. Longitudinal analyses using F-Fluorodeoxyglucose positron emission tomography with computed tomography as a measure of COVID-19 severity in the aged, young, and humanized ACE2 SARS-CoV-2 hamster models. Antiviral Research. 105605. PMID 37068595 DOI: 10.1016/j.antiviral.2023.105605  0.172
2021 De Giorgi V, West KA, Henning AN, Chen L, Holbrook MR, Gross R, Liang J, Postnikova E, Trenbeath J, Pogue S, Scinto T, Alter HJ, Cantilena CC. Anti-SARS-CoV-2 Serology persistence over time in COVID-19 Convalescent Plasma Donors. Medrxiv : the Preprint Server For Health Sciences. PMID 33758897 DOI: 10.1101/2021.03.08.21253093  0.17
2022 Dacon C, Peng L, Lin TH, Tucker C, Lee CD, Cong Y, Wang L, Purser L, Cooper AJR, Williams JK, Pyo CW, Yuan M, Kosik I, Hu Z, Zhao M, ... ... Holbrook MR, et al. Rare, convergent antibodies targeting the stem helix broadly neutralize diverse betacoronaviruses. Cell Host & Microbe. PMID 36347257 DOI: 10.1016/j.chom.2022.10.010  0.158
2022 Epling BP, Rocco JM, Boswell KL, Laidlaw E, Galindo F, Kellogg A, Das S, Roder A, Ghedin E, Kreitman A, Dewar RL, Kelly SEM, Kalish H, Rehman T, Highbarger J, ... ... Holbrook MR, et al. Clinical, Virologic, and Immunologic Evaluation of Symptomatic Coronavirus Disease 2019 Rebound Following Nirmatrelvir/Ritonavir Treatment. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 36200701 DOI: 10.1093/cid/ciac663  0.143
2021 Srivastava K, West KA, De Giorgi V, Holbrook MR, Bovin NV, Henry SM, Flegel WA. COVID-19 Antibody Detection and Assay Performance Using Red Cell Agglutination. Microbiology Spectrum. 9: e0083021. PMID 34878316 DOI: 10.1128/Spectrum.00830-21  0.141
2020 Boonyaratanakornkit J, Morishima C, Selke S, Zamora D, McGuffin S, Shapiro AE, Campbell VL, McClurkan CL, Jing L, Gross R, Liang J, Postnikova E, Mazur S, Chaudhary A, Das MK, ... ... Holbrook MR, et al. Clinical, laboratory, and temporal predictors of neutralizing antibodies to SARS-CoV-2 after COVID-19. Medrxiv : the Preprint Server For Health Sciences. PMID 33052361 DOI: 10.1101/2020.10.06.20207472  0.137
2020 Boonyaratanakornkit J, Morishima C, Selke S, Zamora D, McGuffin SA, Shapiro AE, Campbell VL, McClurkan CL, Jing L, Gross R, Liang J, Postnikova E, Mazur S, Lukin VV, Chaudhary A, ... ... Holbrook MR, et al. Clinical, laboratory, and temporal predictors of neutralizing antibodies to SARS-CoV-2 among COVID-19 convalescent plasma donor candidates. The Journal of Clinical Investigation. PMID 33320842 DOI: 10.1172/JCI144930  0.124
1993 Holbrook MR, Young KE, Gibbon LG, Webster CA, Tranter HS, Arbuthnott JP, Todd I. Stimulation of rat spleen cells by staphylococcal enterotoxins. Fems Immunology and Medical Microbiology. 7: 169-74. PMID 8401429 DOI: 10.1111/J.1574-695X.1993.TB00396.X  0.103
2022 Epling BP, Rocco JM, Boswell KL, Laidlaw E, Galindo F, Kellogg A, Das S, Roder A, Ghedin E, Kreitman A, Dewar RL, Kelly SEM, Kalish H, Rehman T, Highbarger J, ... ... Holbrook MR, et al. COVID-19 redux: clinical, virologic, and immunologic evaluation of clinical rebound after nirmatrelvir/ritonavir. Medrxiv : the Preprint Server For Health Sciences. PMID 35734093 DOI: 10.1101/2022.06.16.22276392  0.1
2023 Dacon C, Peng L, Lin TH, Tucker C, Lee CD, Cong Y, Wang L, Purser L, Cooper AJR, Williams JK, Pyo CW, Yuan M, Kosik I, Hu Z, Zhao M, ... ... Holbrook MR, et al. Rare, convergent antibodies targeting the stem helix broadly neutralize diverse betacoronaviruses. Cell Host & Microbe. 31: 1071-1072. PMID 37321165 DOI: 10.1016/j.chom.2023.05.016  0.084
1997 Holbrook MR, Powell RJ. Is there a future for extracorporeal photochemotherapy in the treatment of the rheumatological diseases? Annals of the Rheumatic Diseases. 56: 339-40. PMID 9227160  0.074
2000 Holbrook MR, Slakey LL, Gross DJ. Thermodynamic mixing of molecular states of the epidermal growth factor receptor modulates macroscopic ligand binding affinity. The Biochemical Journal. 352: 99-108. PMID 11062062  0.069
1996 Holbrook MR, Tighe PJ, Powell RJ. Restrictions of T cell receptor beta chain repertoire in the peripheral blood of patients with systemic lupus erythematosus. Annals of the Rheumatic Diseases. 55: 627-31. PMID 8882133  0.052
2003 Da Forno PD, Holbrook MR, Nunns D, Shaw PA. Long-term follow-up of patients following negative colposcopy: a new gold standard and its implications for cervical screening. Cytopathology : Official Journal of the British Society For Clinical Cytology. 14: 281-6. PMID 14510893  0.032
2003 Holbrook MR, Kendall CH, Shaw PA. An alternate model of thyroid cytology: practical not perfect. Cytopathology : Official Journal of the British Society For Clinical Cytology. 14: 121-5. PMID 12828720  0.032
2000 Cross SS, Betmouni S, Burton JL, Dubé AK, Feeley KM, Holbrook MR, Landers RJ, Lumb PB, Stephenson TJ. What levels of agreement can be expected between histopathologists assigning cases to discrete nominal categories? A study of the diagnosis of hyperplastic and adenomatous colorectal polyps. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 13: 941-4. PMID 11007033 DOI: 10.1038/modpathol.3880171  0.02
1996 Holbrook MR, Doherty M, Powell RJ. Post-traumatic leg ulcer. Annals of the Rheumatic Diseases. 55: 214-5. PMID 8733436  0.016
1997 Powell RJ, Holbrook MR, Stevens A. Pyoderma gangrenosum and its treatment. Lancet (London, England). 350: 1720-1. PMID 9413459 DOI: 10.1016/S0140-6736(05)63568-4  0.01
Hide low-probability matches.